Angiocrine Bioscience, Inc. By efain on Thu, 11/19/2020 - 14:39 Read more about Angiocrine Bioscience, Inc.
An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer Read more about An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
PRG Science and Technology Co., Ltd. By efain on Fri, 10/30/2020 - 12:22 Read more about PRG Science and Technology Co., Ltd.
Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis Read more about Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis
Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI Read more about Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies Read more about Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
